Characteristics of patient-reported worsenings of asthma and/or COPD and concordance with physician-reported exacerbations

<bold>Background:</bold> Exacerbations of asthma and/or COPD are important clinical outcomes but reports of symptom worsening by patients and physicians may differ. <bold>Methods:</bold> NOVELTY (<ext-link>NCT02760329</ext-link>) is an international observational study of patients with physician-assigned asthma and/or COPD. Patient-reported episodes of worsening (PREW) were recorded 3-monthly. Physician recording of exacerbations included information on start date, medications, and medical care. We evaluated characteristics of patients who reported any PREW during the last 3 months of the first follow-up year, by physician-reported exacerbations over the same period. <bold>Results:</bold> Among 5,214 patients with asthma and/or COPD, during the 3 month period, PREW were reported by 56%, 55% and 50% patients with asthma, asthma+COPD, and COPD, respectively. In contrast, an exacerbation was reported, respectively, for 9%, 16% and 12% of patients. Nearly half of PREW events without corresponding exacerbations were treated. Patients with PREW and no exacerbations (vs. both PREW & exacerbation) were more likely male, more frequently current smokers, had higher lung function, lower intensity of respiratory symptoms and fewer physician visits. They also exhibited different comorbidity profile, e.g. less GERD, allergy, bronchiectasis in asthma, less emphysema in COPD. <bold>Conclusion:</bold> Patients with asthma and/or COPD frequently report episodes of treated and untreated PREW without a concomitant diagnosis of exacerbation by their health-care provider. This highlights potential under-reporting of exacerbations in obstructive lung disease, particularly among patients with perceived milder disease or with fewer physician visits.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa2964
Citations
1
Primary Topic
Health Promotion and Cardiovascular Prevention
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristics of patient-reported worsenings of asthma and/or COPD and concordance with physician-reported exacerbations

Laura Belton, Helen Kathryn Reddel, Charles H. Janson, Mohsen Sadatsafavi et al.
1 citations
Health Promotion and Cardiovascular Prevention
0.54
article

Characteristics of patient-reported worsenings of asthma and/or COPD and concordance with physician-reported exacerbations

Laura Belton, Helen Kathryn Reddel, Charles H. Janson, Mohsen Sadatsafavi, Hana Müllerová, Eleni Rapsomaniki, Deven Patel, Alberto Papi, Barry J. Make, Jonathan C. Marshall, Pierre‐Régis Burgel, Bradley E. Chipps, Rod Hughes, For The Novelty Scientific Community And Nove
article en
1 citations

Abstract

<bold>Background:</bold> Exacerbations of asthma and/or COPD are important clinical outcomes but reports of symptom worsening by patients and physicians may differ. <bold>Methods:</bold> NOVELTY (<ext-link>NCT02760329</ext-link>) is an international observational study of patients with physician-assigned asthma and/or COPD. Patient-reported episodes of worsening (PREW) were recorded 3-monthly. Physician recording of exacerbations included information on start date, medications, and medical care. We evaluated characteristics of patients who reported any PREW during the last 3 months of the first follow-up year, by physician-reported exacerbations over the same period. <bold>Results:</bold> Among 5,214 patients with asthma and/or COPD, during the 3 month period, PREW were reported by 56%, 55% and 50% patients with asthma, asthma+COPD, and COPD, respectively. In contrast, an exacerbation was reported, respectively, for 9%, 16% and 12% of patients. Nearly half of PREW events without corresponding exacerbations were treated. Patients with PREW and no exacerbations (vs. both PREW & exacerbation) were more likely male, more frequently current smokers, had higher lung function, lower intensity of respiratory symptoms and fewer physician visits. They also exhibited different comorbidity profile, e.g. less GERD, allergy, bronchiectasis in asthma, less emphysema in COPD. <bold>Conclusion:</bold> Patients with asthma and/or COPD frequently report episodes of treated and untreated PREW without a concomitant diagnosis of exacerbation by their health-care provider. This highlights potential under-reporting of exacerbations in obstructive lung disease, particularly among patients with perceived milder disease or with fewer physician visits.

Uppsala University (SE), Uppsala University Hospital (SE), Inserm (FR), University of Ferrara (IT), Université Paris Cité (FR), Woolcock Institute of Medical Research (AU), National Jewish Health (US), Capital Allergy and Respiratory Disease Center (US), Hôpital Cochin (FR), AstraZeneca (France) (FR), AstraZeneca (Switzerland) (CH), Centre for Advancing Health Outcomes (CA), Institut Cochin (FR), AstraZeneca (Spain) (ES), University of Colorado Denver (US)
Openalex Percentile: Top 27%
Health Promotion and Cardiovascular Prevention
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.